Home Newsletters Mesenchymal Cell News The Transplantation of Rapamycin-Treated Senescent Human Mesenchymal Stem Cells with Enhanced Proangiogenic...

The Transplantation of Rapamycin-Treated Senescent Human Mesenchymal Stem Cells with Enhanced Proangiogenic Activity Promotes Neovascularization and Ischemic Limb Salvage in Mice

By
Justin.choi
-
0
Researchers investigated the effects of rapamycin on the proangiogenic ability of senescent human umbilical cord mesenchymal stem cells.
[Acta Pharmacologica Sinica]

Sorry, but the selected Zotpress account can't be found.

Abstract

RELATED ARTICLES

Exit mobile version